Search Term
Home
About Us
Our Company
Senior Management
Board of Directors
Our Science
Our Challenge
Our Promise
Pipeline
Publications
Our Medicines
ORLYNVAHâ„¢
Investors
Overview
Press Releases
Events & Presentations
Financials & Filings
Stock Information
Analyst Coverage
Corporate Governance
FAQ
News
Press Releases
External News Links
Careers
Career Opportunities
Contact Us
Global Locations
Partnering Opportunities
Search
Back to top
Investors
Investors
Overview
Press Releases
Events & Presentations
Financials & Filings
Quarterly Results
SEC Filings
Stock Information
Analyst Coverage
Corporate Governance
FAQ
Email Alerts
Tear Sheet
Contacts
RSS News Feed
SEC Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B1
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
Year:
View All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Date
Form
Description
PDF
XBRL
Pages
10/04/24
8-K
Current report filing
4
09/30/24
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
3
09/30/24
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
4
09/24/24
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
3
09/24/24
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
3
09/23/24
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
4
09/11/24
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
3
09/09/24
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
4
08/14/24
DEF 14A
Definitive proxy statements
18
08/14/24
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-10.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
129
1
2
3
4
5
6
7
8
9
10